As the biotech approaches $1 billion in sales, Acadia CEO Steve Davis is stepping down and being succeeded by Catherine Owen Adams. Adams most recently led a $20 billion business as senior vice ...
Two biotechs are teaming up to deliver cholesterol-busting mRNA to clogged arteries. | Two biotechs are teaming up to deliver ...
AbbVie plans to share results from another phase 3 trial of tavapadon later this year, the pharma said in the release. That ...
Two of the top 10 largest medtech companies will partner together on robotic head and spine procedures, with Medtronic ...
Biomea Fusion has escaped from the full clinical hold imposed by the FDA. | Biomea Fusion has escaped from the full clinical hold imposed by the FDA. After reviewing the data, the regulator has ...
Spain-based Asabys Partners has closed a fund of 180 million euros ($200 million), money that will go toward 12 to 15 ...
On the heels of a $3 billion fund from Bain Capital Life Sciences, Arch Venture Partners is proving it can go toe-to-toe with ...
The NIH has found evidence of research misconduct against Eliezer Masliah, M.D., the longtime head of the National Institute ...
AstraZeneca is extending its work with Immunai through a multiyear collaboration that aims to implement its ...
Merck & Co. has picked up options on two Evaxion vaccine candidates, paying $3.2 million and dangling more than $1 billion in ...
In July, Biogen and Sage reported the failure of GABAA receptor positive allosteric modulator SAGE-324, also called BIIB124, ...
Flagship hopes biotechs will flock to Mirai’s algorithm-based platform to enhance their genetic meds
Amid the genetic medicines arms race, Flagship Pioneering is unveiling a new company to help biotechs fine-tune the precision ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback